Novalis LifeSciences — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Flywheel provides a platform for organizing, managing, and sharing medical imaging data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US
Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)Colby Moosman(Executive Officer)Matthew D. Michela(Executive Officer, Director)Sarah Fazio(Executive Officer)Danny J. Cunagin(Director)
Board seatMarijn DekkersPaul MeisterDevin Leake· per SEC Form D
Synecta develops cell-derived nanoparticles that activate immune cells for cell therapy manufacturing, improving potency and reducing costs.
BiotechDeep TechMedical DevicesPhiladelphia, US
Peter Keller(Executive Officer, Director)
BoardPaul Meister(Director)Elaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.